AN2 Therapeutics, Inc. Common Stock, Capital Shares Reserved for Future Issuance
AN2 Therapeutics, Inc. (ANTX) had Common Stock, Capital Shares Reserved for Future Issuance of 17.63 million shares as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-08-11
- 2026-06-30: Common Stock, Capital Shares Reserved for Future Issuance 17.63M shares.
- 2026-03-31: Common Stock, Capital Shares Reserved for Future Issuance 17.67M shares.
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 10.83M shares.
- 2025-09-30: Common Stock, Capital Shares Reserved for Future Issuance 10.88M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance |
|---|---|
| 2026-06-30 | 17.63M shares 10-Q · filed 2026-08-11 |
| 2026-03-31 | 17.67M shares 10-Q · filed 2026-05-11 |
| 2025-12-31 | 10.83M shares 10-Q · filed 2026-08-11 |
| 2025-09-30 | 10.88M shares 10-Q · filed 2025-11-12 |
| 2025-06-30 | 11.02M shares 10-Q · filed 2025-08-12 |
| 2025-03-31 | 8.11M shares 10-Q · filed 2025-05-13 |
| 2024-12-31 | 6.83M shares 10-K · filed 2026-03-17 |
| 2024-09-30 | 6.88M shares 10-Q · filed 2024-11-13 |
| 2024-06-30 | 6.92M shares 10-Q · filed 2024-08-13 |
| 2024-03-31 | 6.48M shares 10-Q · filed 2024-05-14 |
| 2023-12-31 | 5.52M shares 10-K · filed 2025-03-25 |
| 2023-09-30 | 5.52M shares 10-Q · filed 2023-11-09 |
| 2023-06-30 | 5.56M shares 10-Q · filed 2023-08-10 |
| 2023-03-31 | 5.56M shares 10-Q · filed 2023-05-11 |
| 2022-12-31 | 4.61M shares 10-K · filed 2024-03-29 |
| 2022-09-30 | 4.42M shares 10-Q · filed 2022-11-09 |
| 2022-06-30 | 4.42M shares 10-Q · filed 2022-08-11 |
| 2022-03-31 | 4.42M shares 10-Q · filed 2022-05-10 |
| 2021-12-31 | 13.94M shares 10-K · filed 2023-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |